Navigation Links
Micromet Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/4/2010

2010 Milestones:

During 2010, the Company intends to:

  • Initiate a European pivotal clinical trial of blinatumomab in patients with MRD-positive adult ALL
  • Initiate a phase 2 clinical trial of blinatumomab in patients with relapsed/refractory adult ALL
  • Initiate a phase 2 clinical trial of blinatumomab in patients with chronic lymphocytic leukemia
  • Discuss the regulatory strategy for blinatumomab in adult ALL with the FDA
  • Discuss the regulatory strategy for blinatumomab in pediatric ALL with the FDA and EMEA  
  • Expand the safety and efficacy experience of blinatumomab in patients with relapsed/refractory non-Hodgkin's lymphoma
  • Continue enrollment in an ongoing phase 1 clinical trial of MT110 in patients with solid tumors
  • Present new data on the Company's pre-clinical BiTE antibodies
  • Present updated results from phase 1 and phase 2 clinical trials of blinatumomab in patients with NHL and ALL at an upcoming medical meeting
  • Present updated results from a phase 1 clinical trial of MT110 in patients with solid tumors at an upcoming medical meeting


'/>"/>
SOURCE Micromet, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Data from Phase 1 Study Confirm High Response Rate of Micromets Blinatumomab in Patients with Non-Hodgkins Lymphoma
2. Micromet, Inc. Reports Second Quarter 2009 Financial Results
3. Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203
4. Micromet, Inc. Reports First Quarter 2009 Financial Results
5. Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference
6. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
7. Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference
8. Micromet, Inc. Reports Second Quarter 2008 Financial Results
9. Micromet, Inc. Reports First Quarter 2008 Financial Results
10. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
11. Micromets BiTE(R) Antibodies Reveal Unique Mode of Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... ... Every year, DUI arrests and fatalities spike on the 4th of July. In fact, because ... when it comes to being on the road. According to attorney David J. Maloney ... of all highway deaths between 2007 and 2011 were caused by drunk driving over the ...
(Date:7/2/2015)... ... , ... no secret that what we consume can have an effect on the body. And during the ... or perhaps even undernourished if not eating enough of the right foods, as well as drinking ... of year to overdo it on the food front as well, with sweet treats like ice ...
(Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, ... Semiconductor Timing announced the release and publication of their newest offering to complement ... publication and Newsletter. , Designed in support of coverage for the full ...
(Date:7/1/2015)... Los Angeles, CA (PRWEB) , ... July 01, 2015 , ... ... enjoy the great outdoors. Yet, in many Middle-Eastern countries like Saudi Arabia and Dubai, ... entirely to relax in more temperate climates. Celebrity dentist Dr. Sam Saleh of ORA ...
(Date:7/1/2015)... York, New York (PRWEB) , ... July 01, ... ... injury lawsuit filed against the manufacturers of Levaquin ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted ... U.S. District Court, Southern District of West Virginia on June 26th, the Court ...
Breaking Medicine News(10 mins):Health News:Attorney David Maloney Stresses Safety through Sobriety 2Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3
... In-Q-Tel Investment in Sonitus Medical Accelerates Development of ... the TeethSAN MATEO, Calif., May 26 Sonitus ... world,s first non-surgical and removable hearing device to ... strategic investment and technology advancement agreement with In-Q-Tel, ...
... on the cholesterol-lowering drugs , , MONDAY, May 25 (HealthDay News) ... risk of a second stroke, new research shows. , The ... a 35 percent lower incidence of second strokes and a ... compared to those who didn,t, according to a report in ...
... the L.A. MarathonLOS ANGELES, May 25 Today,s Los Angeles ... infamous and hugely-plumped characters from the Foster Farms television commercials. ... pass themselves off as fresh, natural and never "plumped" Foster ... entered the duo as part of its "Say No To ...
... Vienna, Austria: The relationship between the dental disease ... for several years. Although a genetic link ... Now, for the first time, scientists have discovered a ... the annual conference of the European Society of Human ...
... of trials finds Avastin with chemo doubles odds ... of the drug bevacizumab (Avastin) in combination with chemotherapy ... patients, new research has found. , These perforations are ... small intestine or large bowel. , Bevacizumab is designed ...
... woman,s death in New York City raises national toll to ... been made towards developing a viable H1N1 swine flu vaccine, ... Prevention saying this week that they have two promising candidate ... 50-year-old woman died of swine flu in New York City ...
Cached Medicine News:Health News:Sonitus Medical Secures Strategic Investment and Technology Advancement Agreement From In-Q-Tel 2Health News:Sonitus Medical Secures Strategic Investment and Technology Advancement Agreement From In-Q-Tel 3Health News:Statins Can Help Prevent Second Stroke 2Health News:Statins Can Help Prevent Second Stroke 3Health News:Scientists find shared genetic link between the dental disease periodontitis and heart attack 2Health News:Cancer Drug May Boost Risk of Gastrointestinal Perforation 2Health News:Viable Swine Flu Shot Closer to Reality 2Health News:Viable Swine Flu Shot Closer to Reality 3Health News:Viable Swine Flu Shot Closer to Reality 4Health News:Viable Swine Flu Shot Closer to Reality 5Health News:Viable Swine Flu Shot Closer to Reality 6Health News:Viable Swine Flu Shot Closer to Reality 7Health News:Viable Swine Flu Shot Closer to Reality 8Health News:Viable Swine Flu Shot Closer to Reality 9Health News:Viable Swine Flu Shot Closer to Reality 10Health News:Viable Swine Flu Shot Closer to Reality 11Health News:Viable Swine Flu Shot Closer to Reality 12Health News:Viable Swine Flu Shot Closer to Reality 13
(Date:7/1/2015)... 1, 2015 Prismic Pharmaceuticals, Inc., a specialty ... foods, today announced the election of Joseph J. ... its Board of Directors. Commenting on the ... Moriarty , Chairman and CEO of Prismic, stated, "We ... Martin Simonetti have accepted our invitation to join ...
(Date:7/1/2015)... , July 1, 2015  Imprimis Pharmaceuticals, Inc. ... on the development and commercialization of proprietary compounded ... ring The Nasdaq stock market closing bell on ... growing success of its Go Dropless™ campaign since ... cataract procedures are performed annually in the U.S. ...
(Date:7/1/2015)... -- ExeGi Pharma, a company focused on developing and ... it has been granted a product license by the ... to sell Visbiome™ in Canada . ... Claudio De Simone , MD, PhD and has been ... recently signed an exclusive agreement with ExeGi Pharma to ...
Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3
... Mass., March 18, 2011 Cytel ... implementation services and software, proudly announced today the ... Baker as Vice President, Clinical Research Services. ... demonstrated biopharmaceutical development leadership at some of the ...
... family of Midland, Michigan have a new lease on ... and Mike ALL underwent Roux-en-Y bariatric surgery ... to offer this life-changing surgery. The surgeries were performed ... The family has lost 445 pounds, and counting. ...
Cached Medicine Technology:Cytel Hires Biopharmaceutical Development Veteran Jim Baker to Support Expansion of its Clinical Research Offerings 2Midland Family Undergoes Bariatric Surgery at Hurley Medical Center--Loses 445 Pounds & Counting—Tells their Life-Saving Story to Media on March 18, 2011 2
The Bledsoe Basic Knee Brace offers a broad range of features that are unmatched by any other brace in its price range. Application of this brace is the easiest of any brace on the market....
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
Comprifix Knee is a comfortable, lightweight, anatomically knitted knee support with an incorporated donut shaped insert for the reduction of pain and swelling....
... Brace features an adjustable extension/flexion stop ... in 10 increments. Adjust without tools. ... the stop pins and reposition them ... washable fabric with Velcro fasteners. All ...
Medicine Products: